Department of Pharmaceuticals Tender by National Institute Of Pharmaceutical Education And Research (niper)mohali (GEM/2025/B/6170527)
CD36 Antibody 100ul,JMJD1C Antibody 100ul,USF1 Antibody 100ul,DNMT1 Antibody 100ul

Tender Timeline
Tender Title: Supply of Antibodies
Tender Reference Number: GEM/2025/B/6170527
Issuing Authority/Department: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
The Supply of Antibodies tender is aimed at procuring critical scientific materials essential for research and development in the fields of pharmaceuticals and life sciences. Specifically, the tender covers the acquisition of the following antibodies in 100ul quantities: CD36 Antibody, JMJD1C Antibody, USF1 Antibody, and DNMT1 Antibody. This procurement is a vital part of advancing scientific studies and healthcare solutions.
Scope of Work and Objectives
The primary objective of this tender is to ensure a timely and reliable supply of specific antibodies which are integral for various research applications. Suppliers are expected to deliver high-quality products, adhering strictly to the technical specifications outlined in the tender documents. The scope includes:
- Timely delivery of all specified antibodies
- Compliance with quality standards and specifications
- Ensuring all products are packaged appropriately to maintain stability and efficacy
Eligibility Criteria
To qualify for this tender, bidders must meet the following eligibility requirements:
- Must be a registered entity with relevant trade licenses
- Provide proof of previous experience in supplying scientific materials or antibodies
- Must comply with all local and national regulations applicable to pharmaceutical suppliers
Technical Requirements
Bidders are required to submit products that conform to the following technical specifications:
- All antibodies must exhibit high specificity and affinity
- Each product should come with a Certificate of Analysis (CoA) proving quality
- Vendors must ensure stability throughout the shelf life of the products
Financial Requirements
Financial considerations for bidders include:
- Submission of a price bid as per the format specified in the tender documentation
- Proof of capability to handle financial transactions related to procurement
Document Submission Details
Bidders must prepare and submit the following documentation:
- Technical proposal detailing compliance with specifications
- Financial proposal with pricing breakdown
- Relevant certifications and business information
All documents must be submitted via the designated electronic portal as specified in the tender details.
Special Provisions
This tender has specific provisions that may benefit Micro, Small, and Medium Enterprises (MSEs) and startups. Eligible bidders may receive preferential treatment during the evaluation process, fostering inclusivity in the procurement process.
Evaluation Process
The tender will undergo a detailed evaluation process based on the following criteria:
- Compliance with technical specifications
- Financial competitiveness
- Previous performance and references
Successful bidders will be notified regarding the acceptance of their proposals following a thorough evaluation.
Delivery Locations
Products are to be delivered to designated laboratories and institutions managed by the Department of Pharmaceuticals, ensuring accessibility and smooth integration into ongoing research projects.
Contact Information
For any inquiries regarding this tender or for submission assistance, please refer to the official communication channels of the Department of Pharmaceuticals.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
6 DocumentsDocuments Required from Seller
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, possessing necessary trade licenses, and demonstrating previous experience in supplying scientific materials relevant to the pharmaceutical sector. It is essential to comply with all applicable local and national regulations to ensure a valid submission.
The technical specifications mandate that all antibodies should exhibit high specificity and affinity. Each product must be accompanied by a Certificate of Analysis (CoA) proving its quality. Vendors are also responsible for ensuring the stability of their products throughout the declared shelf life.
Bidders must be prepared to submit a performance security deposit, which is a standard requirement to safeguard the interests of the issuing department. This often involves providing a guarantee or bond that assures fulfillment of purchase and service agreements as detailed in the tender.
Proposals must be submitted electronically via the designated online portal set by the issuing authority. Bidders should ensure that all requested documents are attached and formatted according to the specifications detailed in the tender guidelines to facilitate a smoother evaluation process.
MSEs may benefit from certain preferential policies during the evaluation process, ensuring their participation and competitiveness in the bidding. Startups are also encouraged to apply, aligning with governmental initiatives aimed at fostering entrepreneurship and promoting indigenous manufacturing.
This tender description and the accompanying FAQs provide essential insights and will aid interested bidders in understanding the requirements and expectations laid out by the Department of Pharmaceuticals for the Supply of Antibodies.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders